Research, news, and myth-busting on peptides, SARMs, and the compounds our community actually searches for.
What the FDA's Compounding Review Means for BPC-157
A look at the FDA's Pharmacy Compounding Advisory Committee review of BPC-157 and what compounding categories actually mean for access.
BPC-157's Human Evidence Gap: What the Research Actually Shows
BPC-157 has zero peer-reviewed human clinical trials. Here's what the frequently cited "100+ studies" actually are.
GHK-Cu Is Trending Fast — Here's What the Actual Science Says
GHK-Cu searches are up over 1,000% year over year. The human evidence is real but much thinner than the current hype suggests.
The February Peptide Reclassification Almost No One Covered
In February 2026, HHS moved 14 of 19 restricted compounding peptides further out of reach. Here's what actually happened and why it matters.
If You Compete in Tested Sport, Know These Peptides Are Banned Outright
BPC-157, TB-500, and CJC-1295 are all prohibited under WADA. A "research peptide" label does not mean it is competition-safe.
What the Enhanced Games Actually Proved (and Didn't)
The Enhanced Games happened in Las Vegas this year with athletes competing openly enhanced. Here's what it demonstrated, and what it didn't settle.
The Retatrutide-Cagrilintide Stack Hype Is Ahead of the Data
The Retatrutide plus Cagrilintide stack is a popular topic online, but no published trial has tested that exact combination. Here's what the actual research supports.
Looking for something specific, or placing a wholesale order? Send us a DM or email.